Final answer:
The claim that scheduling determines targeted groups in drug advertising is False. Scheduling refers neither to audience targeting nor to demographic selection in this context. Drug advertising regulations mandate companies to adhere to FDA-approved uses and balance benefit-risk information.
Step-by-step explanation:
The statement that scheduling determines which groups can be targeted in drug advertising is False. Scheduling, in general terms, could refer to the timing of advertisements or controlled substance classifications, but neither directly dictates the target demographics for drug advertising. Drug advertising is strictly regulated, requiring companies to only advertise drugs for FDA-approved uses, also ensuring that there is a fair balance between the benefits and the risks. A cohort, in the context of studies and advertising, tends to consist of subjects who share specific characteristics. However, the true or false statement provided about a cohort being a group of subjects of different ages, weights, genders, and health statuses is a misleading one, as cohorts are typically more homogeneous to ensure accurate study results or relevant advertising.